Nathanael Gray

Nathanael Gray is a Professor of Chemical and Systems Biology at Stanford University since April 2021 and a Professor at Dana-Farber Cancer Institute since February 2012, where Nathanael leads a research group focused on developing innovative cancer treatments. Additionally, Nathanael has been a Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School since January 2011, directing research on experimental drugs and their biological implications. Previously, Nathanael held the position of Associate Professor at Dana-Farber Cancer Institute and served as Director of Biological Chemistry at the Genomics Institute of the Novartis Research Foundation from 1999 to 2006, overseeing projects in medicinal chemistry related to protein kinases and GPCRs. Nathanael Gray earned a PhD in Chemistry from the University of California, Berkeley, from 1991 to 1998.